Tetraphase has two suit­ors, de­spite strug­gling mar­ket for an­tibi­otics

The mar­ket for an­tibi­otics may be “bro­ken,” but one small an­tibi­ot­ic com­pa­ny is seem­ing­ly in de­mand: Tetraphase Phar­ma­ceu­ti­cals. In March, the com­pa­ny said it had …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.